SMART Clinical Trial Reveals Medtronic Evolut TAVR Treatment Advantages for Women
Written By: Adam Pick, Patient Advocate, Author & Website Founder
Published: December 1, 2024
Big News! In case you missed it, the new SMART Clinical Trial just revealed important treatment advantages for women with aortic stenosis who undergo a Medtronic Evolut TAVR.
To learn more about this landmark study, I traveled to the Women’s Heart Health Congressional Day in Washington, D.C. to interview Dr. Roxana Mehran, a principal investigator of the SMART Clinical Trial. Click here to watch my interview with Dr. Roxana Mehran about the SMART Clinical Trial, TAVR and women’s heart health.
![SMART Clinical Trial - Women's Heart Health with Roxanna Mehran](https://www.heart-valve-surgery.com/Images/heart-health-alert-mehran-600.jpg)
Many thanks to Dr. Mehran for sharing these fascinating new insights about the SMART Clinical Trial specific to women’s hearts and TAVR.
Related Links:
- See the new Medtronic TAVR Procedure Educational Microsite
- Research 50 Leading Heart Teams the Specialize in Medtronic TAVR
- Free eBook: What 7 Facts Should You Know About TAVR?
Keep on tickin!
Adam